TransMedics Long Term Debt 2019-2024 | TMDX
TransMedics long term debt from 2019 to 2024. Long term debt can be defined as the sum of all long term debt fields.
| TransMedics Annual Long Term Debt (Millions of US $) |
|
|---|---|
| 2024 | $509 |
| 2023 | $506 |
| 2022 | $59 |
| 2021 | $35 |
| 2020 | $35 |
| 2019 | $34 |
| 2018 | $34 |
| TransMedics Quarterly Long Term Debt (Millions of US $) |
|
|---|---|
| 2024-12-31 | $509 |
| 2024-09-30 | $509 |
| 2024-06-30 | $508 |
| 2024-03-31 | $507 |
| 2023-12-31 | $506 |
| 2023-09-30 | $505 |
| 2023-06-30 | $505 |
| 2023-03-31 | $59 |
| 2022-12-31 | $59 |
| 2022-09-30 | $59 |
| 2022-06-30 | $35 |
| 2022-03-31 | $35 |
| 2021-12-31 | $35 |
| 2021-09-30 | $35 |
| 2021-06-30 | $35 |
| 2021-03-31 | $35 |
| 2020-12-31 | $35 |
| 2020-09-30 | $35 |
| 2020-06-30 | $34 |
| 2020-03-31 | $34 |
| 2019-12-31 | $34 |
| 2019-09-30 | $34 |
| 2019-06-30 | $34 |
| 2019-03-31 | $34 |
| 2018-12-31 | $34 |
| 2018-09-30 | |
| 2018-06-30 | |
| 2018-03-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $3.059B | $0.442B |
| TransMedics Inc. is a commercial-stage medical technology company. It is engaged in transforming organ transplant therapy for end-stage organ failure patients. The company offers Organ Care System, an integrated, compact, portable preservation technology which addresses unmet need for organs for transplantation. TransMedics Inc. is headquartered in Andover, Massachusetts. | |||